Vote!
UPDATE 1-Prevnar trial results needed for CDC recommendation
Feb 22 (Reuters) - An advisory committee to the U.S. Centers for Disease Control and Prevention said on Wednesday that it will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults aged 50 and older. ...
Published By: Reuters Business - Wednesday, 22 February
- New Yesterday
- Vote! Men are advised to skip routine PSA tests
Star Tribune Health (Today) - A final federal recommendation on the cancer screening found more harm than good....
- Vote! Most men told to skip PSA test
- Vote! New PSA guidelines: what do they mean to you?
MSNBC (Today) - NBC's Robert Bazell answers frequently asked questions about the latest panel recommendation regarding the popular...
- Vote! Peregrine soars as cancer drug meets trial goal
Reuters Health (Yesterday) - (Reuters) - Peregrine Pharmaceuticals Inc said results from a mid-stage trial showed that its key...
